Abbott Reports Q3 Growth and Nutrition Separation Plan

Abbott’s third-quarter update

Abbott Laboratories reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%, according to TradingView’s summary of the company’s Q3 earnings call.

TradingView also reported that Abbott announced plans to separate its nutrition business into an independent publicly traded company. The planned separation would occur through a tax-free distribution to shareholders.

The earnings-call update combines reported quarterly growth with a corporate action involving Abbott’s nutrition business. TradingView identified both items in its coverage of the company’s Q3 discussion.

Separation plan centers on nutrition

According to TradingView, Abbott’s planned transaction would establish the nutrition business as an independent publicly traded company. The publisher described the transaction as a tax-free distribution to shareholders.

The announcement concerns the nutrition business, while the reported third-quarter figures cover Abbott’s sales growth and adjusted earnings-per-share growth. TradingView attributed the earnings-call remarks to Abbott’s chairman and chief executive officer.

Key points for diagnostics and laboratory sales professionals

• TradingView reported third-quarter sales growth of 7%.
• Adjusted earnings per share grew 9%, according to TradingView.
• Abbott announced plans to separate its nutrition business into an independent publicly traded company.
• TradingView reported that the planned separation would be completed through a tax-free distribution to shareholders.

For professionals following diagnostics and laboratory industry business updates, Abbott’s Q3 call provides a reported view of company sales and adjusted earnings-per-share growth alongside a planned change to its nutrition business. TradingView’s report places the quarterly results and the proposed separation at the center of the update.

Abbott’s announcement is limited in TradingView’s summary to the stated plan for an independent publicly traded nutrition company and the tax-free distribution structure. The publisher’s coverage also identifies the reported 7% sales growth and 9% adjusted earnings-per-share growth from the third quarter.